eurogenic claudication physiotherapy trial

Completed

• Conditions: Degenerative lumbar spinal stenosis; Musculoskeletal Diseases; Spondylopathies

• Registration Number: ISRCTN78288224
• Lead Sponsor: niversity of Leeds (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-06-26
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 76

Inclusion Criteria

1. Patients aged 50 or over, either sex
2. Symptoms of neurogenic claudication (walking-induced lower limb symptoms which are relieved in sitting/flexion)
3. Limitation of normal walking tolerance due to symptoms of neurogenic claudication

Exclusion Criteria

1. Clearly defined radicular symptoms (sciatica)
2. Cognitive impairment or medical conditions preventing understanding or participation in trial
3. Symptoms requiring urgent surgical or other intervention (red flags, such as acute equina syndrome)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Swiss Spinal Stenosis Score (Zurich Claudication Score) symptom severity scale at eight weeks.

Secondary Outcome Measures

Name	Time	Method
At twelve months follow-up:<br>1. Oswestry Disability Index<br>2. Visual Analogue Pain Scale (VAS)<br>3. General Well-Being Index